Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome
- PMID: 21625233
- DOI: 10.1038/leu.2011.101
Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome
Abstract
Despite recent therapeutic improvements, the prognosis for patients suffering from Sézary syndrome (SS), a disseminated form of cutaneous T-cell lymphomas, is still poor. We identified bi- and monoallelic deletions of the tumor necrosis factor-α-induced protein 3 gene (TNFAIP3; A20) in a high proportion of SS patients as well as biallelic A20 deletion in the SS-derived cell line SeAx. Furthermore, we demonstrate that inhibition of A20 activates the NF-κB pathway thereby increasing the proliferation of normal T lymphocytes. On the other hand, the reconstitution of A20 expression slowed down the cell cycle in SeAx cells. Recently A20 inactivation has been reported in various B-cell lymphomas. In this study, we show that A20 is also a putative tumor suppressor in the T-cell malignancy-SS.
Similar articles
-
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.Blood. 2009 Sep 17;114(12):2467-75. doi: 10.1182/blood-2008-12-194852. Epub 2009 Jul 16. Blood. 2009. PMID: 19608751
-
Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.Clin Exp Immunol. 2016 May;184(2):183-96. doi: 10.1111/cei.12764. Epub 2016 Feb 23. Clin Exp Immunol. 2016. PMID: 26724675 Free PMC article.
-
Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLL.Int J Cancer. 2011 Apr 1;128(7):1747-50. doi: 10.1002/ijc.25497. Epub 2010 Jun 7. Int J Cancer. 2011. PMID: 20533286
-
The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.Trends Immunol. 2009 Aug;30(8):383-91. doi: 10.1016/j.it.2009.05.007. Epub 2009 Jul 28. Trends Immunol. 2009. PMID: 19643665 Review.
-
Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease.Biochem Soc Trans. 2011 Aug;39(4):1086-91. doi: 10.1042/BST0391086. Biochem Soc Trans. 2011. PMID: 21787353 Review.
Cited by
-
Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome.Oncotarget. 2017 Jun 13;8(24):39627-39639. doi: 10.18632/oncotarget.17383. Oncotarget. 2017. PMID: 28489605 Free PMC article.
-
A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.PLoS One. 2013;8(2):e56741. doi: 10.1371/journal.pone.0056741. Epub 2013 Feb 13. PLoS One. 2013. PMID: 23418597 Free PMC article.
-
The role of aberrant proteolysis in lymphomagenesis.Curr Opin Hematol. 2015 Jul;22(4):369-78. doi: 10.1097/MOH.0000000000000156. Curr Opin Hematol. 2015. PMID: 26049759 Free PMC article. Review.
-
A novel method of amplified fluorescent in situ hybridization for detection of chromosomal microdeletions in B cell lymphoma.Int J Hematol. 2019 May;109(5):593-602. doi: 10.1007/s12185-019-02617-x. Epub 2019 Mar 4. Int J Hematol. 2019. PMID: 30830578
-
Inhibitory feedback control of NF-κB signalling in health and disease.Biochem J. 2021 Jul 16;478(13):2619-2664. doi: 10.1042/BCJ20210139. Biochem J. 2021. PMID: 34269817 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical